Celecoxib Capsules Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules
Available Strengths: 50 mg, 100 mg, 200 mg, 400 mg
Reference Brands: Celebrex(US)
Category:
Arthritis
Celecoxib selectively inhibits COX-2 enzyme, reducing prostaglandin synthesis responsible for pain and inflammation. It effectively treats arthritis and acute pain, offering benefits like targeted relief, fewer gastrointestinal side effects, and improved safety for long-term use. Its selective action maintains protective COX-1 functions, enhancing tolerability.
Celecoxib Capsules is available in Oral Capsules
and strengths such as 50 mg, 100 mg, 200 mg, 400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Celecoxib Capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Celecoxib Capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Celecoxib tablets are approved in the EU and US for managing rheumatoid arthritis, osteoarthritis, and acute pain. In the EU, brands like Celebrex (by Pfizer) are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on extensive clinical data with generic versions also available. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market entry for celecoxib tablets, ensuring adherence to European and American standards for safe, effective pain and inflammation management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing